Affordable Insulin Now Act of 2023

The Affordable Insulin Now Act of 2023 would require private health insurance plans and group health plans to limit cost-sharing for insulin to no more than $35 per 30-day supply or 25% of the negotiated price, whichever is lower. It would mandate coverage of a variety of insulin types and dosage forms, ensuring that cost-sharing counts toward annual deductibles and out-of-pocket maximums. The bill also creates a reimbursement program to pay qualifying healthcare providers for insulin furnished to uninsured individuals, covering the difference between what the individual would pay and $35 per 30-day supply. This legislation would directly affect millions of people with diabetes who rely on insulin and have private health insurance or are uninsured. The bill would take effect for plan years beginning January 1, 2024.